Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "blood-tests"

18 News Found

Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools
Biotech | May 02, 2022

Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools

Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education


Datar Cancer Genetics partners with Kokilaben Hospital to offer advanced cancer tests
Healthcare | March 06, 2022

Datar Cancer Genetics partners with Kokilaben Hospital to offer advanced cancer tests

A simple blood test detects over 30 types of cancers


Mapmygenome launches Genomics Experience Centre in Bengaluru
Biotech | March 02, 2022

Mapmygenome launches Genomics Experience Centre in Bengaluru

At the new centre, customers get a real-time experience of the process of genetic testing and actionable plans in preventive healthcare under the expertise of certified genetic counsellors


Hekka Labs introduces decentralized chronic disease data management in South Asia
Digitisation | January 14, 2022

Hekka Labs introduces decentralized chronic disease data management in South Asia

Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase


Twin Health raises US $ 140 million in Series C funding
Startup | October 07, 2021

Twin Health raises US $ 140 million in Series C funding

The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service


NHS UK gives green light to a company to detect early-stage cancer by a simple blood test
News | September 14, 2021

NHS UK gives green light to a company to detect early-stage cancer by a simple blood test

Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025


Delfi liquid biopsy shows promise for reducing lung cancer deaths
Biotech | August 23, 2021

Delfi liquid biopsy shows promise for reducing lung cancer deaths

When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers


Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests
Digitisation | August 10, 2021

Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests

Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection